The computer-assisted personalized sedation system used in the study was the SEDASYS System. The study was carried out in multiple healthcare settings, including four ambulatory surgery centers, three endoscopy centers and one academic center. Researchers studied the use of SEDASYS on 1,000 patients undergoing routine colonoscopy or EGD. Of these patients, 496 patients were selected for the SEDASYS group, and 504 patients underwent the current standard of care, which is a combination of benzodiazepine and opioid.
Results showed patients in the SEDASYS group were significantly more satisfied than patients who underwent the current standard of care. Additionally, SEDASYS patients recovered sooner and experienced a lower incidence of adverse events than the current-standard-of-care group. Clinician satisfaction was also higher with the SEDASYS group than the current-standard-of-care group.
Read the report about SEDASYS.
Read other coverage about sedation during colonoscopy:
– FDA Reconsiders Approval of Personalized Sedation System
– Hawaii’s Largest Insurer Discouraging Propofol for Colonoscopy
– Study: Patient Tolerance for Unsedated Colonoscopy Improved by Novel Water Method
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.